
A recent Danish study, the POTCAST trial, reveals that maintaining high-normal potassium levels can significantly reduce dangerous heart problems, especially for high-risk individuals with implanted cardioverter defibrillators. The study emphasizes the importance of careful monitoring and medical supervision to balance the benefits and risks of potassium supplementation for optimal heart health.